Tfct-Nib Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Tofacitinib (5mg)
Overview Tfct-Nib Tablet
Nibifect tablets are indicated for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. They alleviate joint pain, tenderness, and swelling by suppressing inflammation, and help retard the progression of bone and joint deterioration. Nibifect may be administered alone or in conjunction with other medications. The tablets can be taken with or without food, ideally at the same time daily. Dosage is determined by your condition and other medications. Always adhere to your physician's instructions; discontinue use only under their guidance, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events like blood clots and gastrointestinal perforation require immediate medical attention. Discuss any concerns regarding side effects with your doctor. Pre-treatment blood work may be necessary, and the medication should not be initiated if you have an infection. Prior to commencing treatment, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Nibifect increases susceptibility to infections and may worsen existing ones; minimize contact with contagious individuals (e.g., those with chickenpox, measles, influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless deemed beneficial by your physician. Regular monitoring by your doctor may be required.
Uses of Tfct-Nib Tablet
Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Major Benefits of Tfct-Nib Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tfct-Nib Tablet whole; do not chew, crush, or divide it. While you may consume it with or without food, consistent timing is recommended.
Common Side effects of Tfct-Nib Tablet:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Tfct-Nib Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tfct-Nib Tablets can be administered with or without food, although consistent timing is recommended.
How Tfct-Nib Tablet works:
Tfcnibu tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This reduces immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tfct-Nib tablets poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Tfct-Nib tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tfct-Nib Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Tfct-Nib Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Tfct-Nib Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with significant hepatic impairment should exercise caution when using Tfct-Nib Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tfct-Nib Tablet :
Should you forget a Tfct-Nib Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tfct-Nib Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolopyrimidine compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Action Class | JAK inhibitors |





